ASN95 -- Selected abstracts: Progression of Renal Failure


Sun. Nov. 5 1995

9:30 A.M. ---Poster--- San Diego Conv Ctr Halls A and B
Determination of progression

Program number 83 Board# S83 at 10:45 A.M.
* Lp(a) and progression of renal insufficiency. O. Samuelsson, P-O. Attman, C. Knight-Gibson, R. Larsson, H. Mulec, L. Weiss and P. Alaupovic. - Goteborg, Sweden and Oklahoma City, OK.

Program number 85 Board# S85 at 10:45 A.M.
* Lipid abnormalities contribute to accelerated progression of human chronic glomerulonephritis. O.Samuelsson, P-O. Attman, C. Knight-Gibson, R. Larsson, H. Mulec, L. Weiss and P. Aluapovic. - Goteborg, Sweden and Oklahoma City, OK.

Program number 91 Board# S91 at 10:45 A.M.
* Effect of dietary protein restriction on the progression of non-diabetic renal disease: Meta-analysis. M.T. Pedrini, J. Lau, A.S.Levey, T.C. Chalmers and P.H. Wang. - Boston, MA and irvine, CA.

Program number 96 Board# S96 at 10:45 A.M.
* Does the a1166c polymorphism in the angiotensin type 1 receptor gene have an influence on the progression to renal failure? H. Yoshida, A.Hamaguchi, M. Shimoda, T. Eto, T. Kawamura, T. Hunley, V. Kon, T. Mitarai and O. Sakai. - Tokyo, Japan and Nashville, TN.

Program number 98 Board# S98 at 10:45 A.M.
* The deletion polymorphism in the ACE gene is a risk factor for the progression to renal failure independent of the m235t polymorphism in the angiotensinogen gene. A. Hamaguchi, H. Yoshida, Y. Miyazaki, T. Kawamura, T. Mitarai and o.Sakai. - Tokyo, Japan.

Program number 108 Board# S108 at 10:45 A.M.
* Urinary transforming growth factor beta1 and progression of glomerular diseases. E. Honkanen, A-M. Teppo, T. Tornroth and C.Gronhagen-Riska. - Helsinki, Finland.

9:30 A.M. ---Poster--- San Diego Conv Ctr Halls A and B
IGA nephropathy

Program number 121 Board# S121 at 10:45 A.M.
* An artificial neural network can select patients at high risk of developing progressive IGA nephropathy more accurately than experienced nephrologists. C.C. Geddes, J.G. Fox, M.E.M. Allison, J.M. Boulton-Jones and K. Simpson. - Glasgow, United Kingdom.


Program number 150 Board# S150 at 10:45 A.M.
* Anti-HIV therapy does affect progression of HIV nephropathy in children. J. Strauss, C. Abitbol, G. Zilleruelo, R. Duncan, E. Rojas and G. Scott. - Miami, Fl.

9:30 A.M. ---Poster--- San Diego Conv Ctr Halls A and B
Diabetes mellitus

Program number 431 Board# S431 at 10:45 A.M.
* Assessment of GFR and progression of kidney function in incipient and overt diabetic nephropathy using the plasma clearance of 51Cr-EDTA. H.P. Hansen, P. Rossing, E.R. Mathiesen, E. Hommel and H-H. Parving. - Gentofte, Denmark.

Program number 434 Board# S434 at 10:45 A.M.
* Progression of overt diabetic nephropathy: Role of metabolic control. H. Mulec, G. Blohme, B. Grande and S. Bjorck. - Goteborg and Trollhattan, Sweden.

Program number 441 Board# S441 at 10:45 A.M.
* Progression of diabetic nephropathy and the insertion/deletion polymorphism of the angiotensin-I-converting enzyme gene. L. Tarnow, P. Rossing, P. Jacobsen, F.S. Nielsen, F. Cambien, L. Lecerf, O. Poirier and H-H. Parving. - Gentofte, Denmark and Paris, France.

Mon. Nov. 6 1995

9:00 A.M. ---Poster--- San Diego Conv Ctr Halls A and B
Renal failure in children

Program number 878 Board# M147 at 10:00 A.M.
* Progression rate of chronic renal failure in children with different nephropathies. U. Berg - Huddinge, Sweden.

9:00 A.M. ---Poster--- San Diego Conv Ctr Halls A and B
Basic immunology: Fibroinflammatory responses

Program number 1112 Board# M381 at 10:00 A.M.
* Enhanced induction of nitric oxide synthesis as a possible factor in the progression of immune-mediated glomerulonephritis. M. Ketteler, E. De Heer, F. Abou-Rebiyeh, A. Gawlik, H. Peters, R. Westenfeld and A. Distler. - Berlin, Germany and leiden, The Netherlands.

4:00 P.M. ---minisymposia--- San Diego Conv Ctr Rm 2

Diabetic nephropathy

Program number 1344 at 5:45
*Effect of nondihydropyridine calcium antagonists on progressionof nephropathy from noninsulin dependent diabetes: A five year follow-up study. G.L. Bakris, J.B. Copley, N. Vicknair and S. Leurgans. - New Orleans, LA and Chicago, IL.

Tue. Nov. 7 1995

9:00 A.M. ---Poster--- San Diego Conv Ctr Halls A and B
Growth hormone

Program number 1999 Board# T549 at 10:00 A.M.
* Long-term effect of recombinant human growth hormone on progression of end-stage renal disease. T. Sanaka, M. Shinobe, M. Omata, H. Nihei, H. Kawaguchi, K. Ito and N. Sugino. - Tokyo, Japan.

Program number 2003 Board# T553 at 10:00 A.M.
* A possible participation of tubular-excreted organic acids in progression of end-stage renal disease: Production of free radicals and tubular damage due to OA. T. Sanaka, H. Nishimura, H. Hayashi, C. Higuchi, M. Ise and N. Sugino. - Tokyo, Japan.

Wed. Nov. 8 1995

10:00 A.M. ---Free Communications--- San Diego Conv Ctr Rm 3
Infection and glomerular disease

Program number 2206 at 11:15
*Prednisone ameliorates the progression of HIV-associated nephropathy. M. Rahman, A. Austen, R. Brown, M. Phinney, J. Carey, R. Kalayjian, K. Weigel and M.C. Smith. - Cleveland, OH.

10:00 A.M. ---Free Communications--- San Diego Conv Ctr Rm 4
Renin angiotensin system: Polymorphism and renal disease

Program number 2248 at 10:15
*ACE gene polymorphism and progression of renal disease. P.N. Harden, C. Geddes, P.A. Rowe, M. Boulton-Jones, J.D. Briggs, B.J.R. Junor, R.S.C.R. Rodger, M.A. McMillan, J.M.C. Connell and A.G. Jardine. - Glasgow, United Kingdom.

Program number 2250 at 10:45
*The insertion/deletion polymorphism in the angiotensin-I-converting enzyme gene predicts the progression of diabetic nephropathy during ACE inhibition in insulin dependent diabetic patients. P. Jacobsen, L. Tarnow, P. Rossing, F. Cambien, L. Lecerf, O. Poirier and H-H. Parving. - Gentofte, Denmark and Paris, France.


Program number 2253 at 11:30
* Accelerated progression to renal failure in NIDDM patients with the deletion polymorphism of the angiotensin converting enzyme gene. H. Yoshida, A. Hamaguchi, T. Mitarai, S. Kuriyama, T.Kawamura, H. Tomonari, T. Eto, H. Kubo, Y. Kawaguchi, K. Matsuoka, Y. Atsumi, I. Ichikawa and O. Sakai. - Tokyo, Japan and Nashville, TN.

Use BACK arrow on your browser (faster) or click here to go back to ASN95 main page

UP Click on ARROW for HDCN Home Page.